Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
A20010017	布地奈德/福莫特罗吸入粉雾剂	budesonide;formoterol fumarate	Inhalation	Chemical Drugs	New Drug Application	2001-05-11	阿斯特拉（无锡）制药有限公司	Astrazeneca Pharmaceutical Co Ltd	Approval Completed-Pending Certificated	2003-01-24	view
CXLB00010	布地奈德/福莫特罗复方粉雾吸入剂	budesonide;formoterol fumarate	Inhalation	Chemical Drugs(3)	New Drug Application	2000-11-24	北京阿里斯临床研究有限公司		In Approval		view
JYHL2100002	布地奈德福莫特罗吸入粉雾剂	budesonide;formoterol fumarate	Inhalation	Chemical Drugs(5.2)	Import Drug Application	2021-02-11		Orion Corporation	In Review	2021-02-11	view
JYHL2100001	布地奈德福莫特罗吸入粉雾剂	budesonide;formoterol fumarate	Inhalation	Chemical Drugs(5.2)	Import Drug Application	2021-02-11		Orion Corporation	In Review	2021-02-11	view
JYHL2100003	布地奈德福莫特罗吸入粉雾剂	budesonide;formoterol fumarate	Inhalation	Chemical Drugs(5.2)	Import Drug Application	2021-02-11		Orion Corporation	In Review	2021-02-11	view
JTH2400027	布地奈德福莫特罗吸入粉雾剂安慰剂	budesonide;formoterol fumarate	Inhalation	Chemical Drugs	Disposable Import Drug Application	2024-02-29					view
CXHL2300939	布地奈德福莫特罗吸入粉雾剂（胶囊型）	budesonide;formoterol fumarate	Inhalation	Chemical Drugs(2.2)	New Drug Application	2023-09-01		Zhuhai Resproly Pharmaceutical Technology Co Ltd			view
JYHB0901101	布地奈德福莫特罗粉吸入剂	budesonide;formoterol fumarate	Inhalation	Chemical Drugs	Supplementary Application	2010-01-14	AstraZeneca AB	AstraZeneca AB	Filed	2010-05-21	view
JYHB1701500	布地奈德福莫特罗粉吸入剂	budesonide;formoterol fumarate	Inhalation	Chemical Drugs	Supplementary Application	2017-12-13	阿斯利康投资（中国）有限公司	Astrazeneca Investment (China) Co Ltd	Certificate Issued	2018-03-20	view
JXHL1400062	布地奈德福莫特罗粉吸入剂	budesonide;formoterol fumarate	Inhalation	Chemical Drugs	Import Drug Application	2014-03-12	阿斯利康制药有限公司	Astrazeneca Pharmaceutical Co Ltd	Certificate Issued	2015-04-20	view
JYHB0500728	布地奈德福莫特罗粉吸入剂	budesonide;formoterol fumarate	Inhalation	Chemical Drugs	Supplementary Application	2005-11-09	Draco Lakemedel AB	Draco Lakemedel AB	Certificate Issued	2006-03-23	view
JYHB1601706	布地奈德福莫特罗粉吸入剂	budesonide;formoterol fumarate	Inhalation	Chemical Drugs	Supplementary Application	2016-12-30	AstraZeneca AB	AstraZeneca AB	Certificate Issued	2017-05-10	view
JXHS0800025	布地奈德福莫特罗粉吸入剂	budesonide;formoterol fumarate	Inhalation	Chemical Drugs	Import Drug Application	2008-05-05	AstraZeneca AB	AstraZeneca AB	Certificate Issued	2009-10-16	view
JYHB1701492	布地奈德福莫特罗粉吸入剂	budesonide;formoterol fumarate	Inhalation	Chemical Drugs	Supplementary Application	2017-11-29	阿斯利康投资（中国）有限公司	Astrazeneca Investment (China) Co Ltd	Filed	2018-02-02	view
JYHB1000455	布地奈德福莫特罗粉吸入剂	budesonide;formoterol fumarate	Inhalation	Chemical Drugs	Supplementary Application	2010-06-03	AstraZeneca AB	AstraZeneca AB	Certificate Issued	2013-04-16	view
J0400059	布地奈德福莫特罗粉吸入剂	budesonide;formoterol fumarate	Inhalation	Chemical Drugs	Supplementary Application	2004-06-11	AstraZeneca AB (A wholly owned subsidiary company of AstraZeneca UK Ltd.)	AstraZeneca AB	Pending Approval	2005-01-24	view
JYHB1800531	布地奈德福莫特罗粉吸入剂	budesonide;formoterol fumarate	Inhalation	Chemical Drugs	Supplementary Application	2018-05-10	AstraZeneca AB	AstraZeneca AB	Certificate Issued	2018-07-10	view
JYHB1501912	布地奈德福莫特罗粉吸入剂	budesonide;formoterol fumarate	Inhalation	Chemical Drugs	Supplementary Application	2015-12-14	AstraZeneca AB	AstraZeneca AB	Certificate Issued	2019-07-01	view
JXHL0700010	布地奈德福莫特罗粉吸入剂	budesonide;formoterol fumarate	Inhalation	Chemical Drugs(3.4)	Import Drug Application	2007-01-18	AstraZeneca AB	AstraZeneca AB	Certificate Issued	2009-02-12	view
JYHB1701271	布地奈德福莫特罗粉吸入剂	budesonide;formoterol fumarate	Inhalation	Chemical Drugs	Supplementary Application	2017-09-30	AstraZeneca AB	AstraZeneca AB	Filed	2017-10-13	view